ESMO 2023: A new immunotherapy, volrustomig, for the first-line treatment of advanced kidney cancer By Sharon Deveson Kell|2023-10-31T09:16:21+00:0031 Oct 2023|Drug treatments| Blocking the action of two proteins in cancer cells (PD-1 [...] Read More Comments Off on ESMO 2023: A new immunotherapy, volrustomig, for the first-line treatment of advanced kidney cancer